Gladstone Institutional Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $442K | Buy |
11,514
+22
| +0.2% | +$845 | 0.02% | 528 |
|
|
2025
Q1 | $445K | Sell |
11,492
-729
| -6% | -$28.2K | 0.02% | 493 |
|
|
2024
Q4 | $413K | Buy |
12,221
+407
| +3% | +$13.8K | 0.02% | 513 |
|
|
2024
Q3 | $483K | Buy |
11,814
+1,410
| +14% | +$57.6K | 0.02% | 458 |
|
|
2024
Q2 | $401K | Sell |
10,404
-900
| -8% | -$34.6K | 0.02% | 473 |
|
|
2024
Q1 | $485K | Sell |
11,304
-56
| -0.5% | -$2.4K | 0.03% | 421 |
|
|
2023
Q4 | $421K | Sell |
11,360
-333
| -3% | -$12.3K | 0.02% | 447 |
|
|
2023
Q3 | $424K | Sell |
11,693
-495
| -4% | -$17.9K | 0.03% | 415 |
|
|
2023
Q2 | $434K | Sell |
12,188
-371
| -3% | -$13.2K | 0.03% | 432 |
|
|
2023
Q1 | $447K | Buy |
12,559
+660
| +6% | +$23.5K | 0.03% | 432 |
|
|
2022
Q4 | $418K | Buy |
11,899
+4,444
| +60% | +$156K | 0.03% | 434 |
|
|
2022
Q3 | $219K | Sell |
7,455
-481
| -6% | -$14.1K | 0.02% | 565 |
|
|
2022
Q2 | $432K | Sell |
7,936
-2,248
| -22% | -$122K | 0.03% | 440 |
|
|
2022
Q1 | $555K | Sell |
10,184
-7,133
| -41% | -$389K | 0.04% | 409 |
|
|
2021
Q4 | $955K | Buy |
17,317
+11,122
| +180% | +$613K | 0.07% | 271 |
|
|
2021
Q3 | $296K | Buy |
+6,195
| New | +$296K | 0.03% | 431 |
|
|
2020
Q4 | – | Sell |
-6,526
| Closed | -$307K | – | 310 |
|
|
2020
Q3 | $307K | Buy |
+6,526
| New | +$307K | 0.07% | 205 |
|
|
2020
Q1 | – | Sell |
-4,442
| Closed | -$261K | – | 289 |
|
|
2019
Q4 | $261K | Sell |
4,442
-1,531
| -26% | -$90K | 0.06% | 212 |
|
|
2019
Q3 | $319K | Sell |
5,973
-565
| -9% | -$30.2K | 0.08% | 194 |
|
|
2019
Q2 | $327K | Buy |
+6,538
| New | +$327K | 0.1% | 188 |
|